Page last updated: 2024-10-24

bupivacaine and Alport Syndrome

bupivacaine has been researched along with Alport Syndrome in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research Excerpts

ExcerptRelevanceReference
"We aim to describe management of a patient receiving renal transplantation for chronic renal failure due to Alport syndrome with low dose of intrathecal bupivacaine and continuous epidural infusion of local anesthetic."3.83Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report. ( Brazzi, L; Bretto, P; Donadio, PP; Gobbi, F; Sales, G, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gobbi, F1
Sales, G1
Bretto, P1
Donadio, PP1
Brazzi, L1

Other Studies

1 other study available for bupivacaine and Alport Syndrome

ArticleYear
Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report.
    Transplantation proceedings, 2016, Volume: 48, Issue:9

    Topics: Adult; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Spinal; Anestheti

2016